H.R. 1781
Referred to CommitteePayment Commission Data Act of 2019
Latest Action
Received in the Senate and Read twice and referred to the Committee on Finance.
10/29/2019 • Senate
Summary
Payment Commission Data Act of 2019
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Passed House • 10/28/2019
Topics & Subjects
CBO Cost Estimates (1)
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (30)
Party Breakdown
Sponsor
Cosponsors (29)
Bill Journey
Originated in the House
Introduced
March 14, 2019
Committee Review
March 27, 2019
Forwarded by Subcommittee to Full Committee by Voice Vote .
Floor Debate
October 28, 2019
Passed Chamber
October 28, 2019
Other Chamber
President
Enacted into Law
Text Versions (4)
Committee Reports (1)
Related Bills (6)
H.R. 19
Lower Costs, More Cures Act of 2019
S. 2543
Prescription Drug Pricing Reduction Act of 2019
H.R. 1264
Payment Commission Data Act of 2019
S. 3129
Lower Costs, More Cures Act of 2019
S. 4199
Prescription Drug Pricing Reduction Act of 2020
S. 801
A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.